|
| Issue Date | Title | Author(s) |
| 2024 | Advances in non-Hydroxamate based Histone Deacetylase Inhibitors as Anticancer Agents | Nabih, Nadine W; Jaballah, Maiy Y; Serya, Rabah ; Abouzid, Khaled AM |
| Jun-2024 | Advances in the discovery of activin receptor-like kinase 5 (ALK5) inhibitors | Mansour, Mai A; Hassan, Ghaneya S; Jaballah, Maiy Y; Abouzid, Khaled A M; Serya, Rabah |
| 25-May-2018 | Alkoxyphenylthiazoles with broad-spectrum activity against multidrug-resistant gram-positive bacterial pathogens | ElAwamy, Moustafa; Mohammad, Haroon; Hussien, Abdelrahman; Abutaleb, Nader S; Hagras, Mohamed; Serya, Rabah ; Taher, Azza T; Seleem, Mohamed N; Mayhoub, Abdelrahman S; Khaled A M Abouzid |
| 2023 | AML and FLT3: An update on FDA-approved or under review kinase inhibitors targeting FLT3 kinase | Nada Alaa El-Deen; Mai Jaballah; Abouzid, Khaled ; Dokla, Eman ; Serya, Rabah |
| 2016 | Anti-acetylcholinesterase activity of essential oils and their major constituents from four Ocimum species | Ezzat, Shahira M; Salama, Maha M; Tadros, Mariane G; Serya, Rabah ; Farag, Mohamed A |
| Mar-2013 | Assessment of new anti-HER2 ligands using combined docking, QM/MM scoring and MD simulation | Ahmed, Marawan; Sadek, Maiada M; Serya, Rabah ; Kafafy, Abdel-Hamid N; Wang, Feng; Khaled A M Abouzid |
| 15-Feb-2006 | The benefits of the multi-target approach in drug design and discovery pp 896--897 | Espinoza-Fonseca, L Michel; Ismail, Mohamed AH; Aboul-Enein, Mohamed NY; Abouzid, Khaled AM; Serya, Rabah |
| 30-Jan-2017 | Click and Release: SO2 Prodrugs with Tunable Release Rates | Serya, Rabah ; Khaled A.M.abouzid; Deena S.Lasheen; Xingyue Ji; Binghe Wang; Khaled A M Abouzid |
| 1-Jul-2025 | Design and synthesis of novel Hydroxamate and non-Hydroxamate HDAC inhibitors based on Chromone and Quinazolone scaffolds | Ashraf, Rosaline; Adel, Mai ; Ibrahim, Esraa; Haffez, Hesham; Soror, Sameh; Abouzid, Khaled A M; Serya, Rabah |
| 2016 | Design and Synthesis of quinazoline derivatives: Biological evaluation for their Anticancer and VEGFR inhibitory activities | Metwally, Wegdan M; Hegazy, G; Serya, Rabah ; Eid, S; Abou El Ella, DA |
| 2016 | Design and synthesis of some new tri-substituted pyrazole derivatives as anticancer agents | Fahmy, Hoda H; Srour, Aladdin M; Khater, Mai A; El-Manawaty, May A; Serya, Rabah ; Ismail, Mohamed A |
| 2016 | Design, synthesis and biological evaluation of indazole–pyrimidine based derivatives as anticancer agents with anti-angiogenic and antiproliferative activities | Elsayed, Nevine M. Y.; Abou El Ella, Dalal ; Serya, Rabah A. T. ; Tolba, Mai F.; Shalaby, Raed; Khaled A M Abouzid |
| 2015 | Design, synthesis and biological evaluation of novel quinazoline-based anti-inflammatory agents acting as PDE4B inhibitors | Serya, Rabah ; Abbas, Abeer Hussin; Ismail, Nasser Saad Mohamed; Esmat, Ahmed; Abou El Ella, Dalal ; Abeer Abdelhafiz |
| 2019 | Design, synthesis and molecular docking of novel pyrazolo[1,5-a][1,3,5]triazine derivatives as CDK2 inhibitors | Oudah, Khulood H; Najm, Mazin A A; Samir, Nermin ; Serya, Rabah ; Khaled A M Abouzid |
| Dec-2014 | Design, synthesis, 3D pharmacophore, QSAR, and docking studies of carboxylic acid derivatives as Histone Deacetylase inhibitors and cytotoxic agents | Abdel-Atty, Mona M; Farag, Nahla A; Kassab, Shaymaa E; Serya, Rabah ; Khaled A M Abouzid |
| 2019 | Design, synthesis, biological evaluation and dynamics simulation of indazole derivatives with antiangiogenic and antiproliferative anticancer activity | Elsayed, Nevine M Y; Serya, Rabah ; Tolba, Mai ; Ahmed, Marawan; Barakat, Khaled; Abou El Ella, Dalal ; Khaled A M Abouzid |
| 2026 | Design, synthesis, in silico, and biological evaluation of novel pyrazolopyrimidinone-based estrogen receptor inhibitors | Hesham, Sara A; Ziko, Laila; Serya, Rabah ; Farag, Nahla A; Mowafy, Samar; Shahin, Mai I; Abouzid, Khaled |
| Nov-2015 | Development of Potent Adenosine Monophosphate Activated Protein Kinase (AMPK) Activators | Fang, Chun-Sheng; Lai, Po-Ting; Kulp, Samuel K; Serya, Rabah ; Ismail, Nasser S M; Chen, Ching-Shih; Dokla, Eman ; Khaled A M Abouzid |
| Sep-2025 | Discovery of Furopyrimidine-Pyrazole Hybrid Compounds Targeting p53-MDM2 Interaction as Anticancer Agents | Mansour, Mai A; Hassan, Ghaneya S; Jaballah, Maiy Y; Dege, Necmi; Şahin, Onur; Sharaky, Marwa; Zhang, Xiaoliang; Su, Ruixin; Kong, Dexin; Abouzid, Khaled A M; Serya, Rabah |
| Apr-2014 | Discovery of new HER2/EGFR dual kinase inhibitors based on the anilinoquinazoline scaffold as potential anti-cancer agents | Sadek, Maiada M; Serya, Rabah ; Kafafy, Abdel-Hamid N; Ahmed, Marawan; Wang, Feng; Khaled A M Abouzid |
| Aug-2021 | Discovery of potent thieno[2,3-d]pyrimidine VEGFR-2 inhibitors: Design, synthesis and enzyme inhibitory evaluation supported by molecular dynamics simulations | Elrazaz, Eman ; Serya, Rabah A T ; Ismail, Nasser S M; Albohy, Amgad; Abou El Ella, Dalal ; Khaled A M Abouzid |
| 15-Apr-2016 | Discovery of Potent VEGFR-2 Inhibitors based on Furopyrimidine and Thienopyrimidne Scaffolds as Cancer Targeting Agents | Aziz, Marwa A; Serya, Rabah A T ; Lasheen, Deena S. ; Mansour, Ahmed M; Ahmed Esmat ; Singab A. ; Khaled A M Abouzid ; Abdel-Aziz, Amal Kamal |
| 17-Jul-2017 | Fragment-Based Drug Discovery in the Bromodomain and Extra-Terminal Domain Family | Radwan, Mostafa; Serya, Rabah |
| 2016 | Furo[2,3-d]pyrimidine based derivatives as kinase inhibitors and anticancer agents | Aziz, M.A. ; Serya, RAT; Lasheen, DS; Abouzid, Khaled ; Serya, Rabah |
| 2015 | Future Journal of Pharmaceutical Sciences | Elsayed, Nevine MY; Abou El Ella, Dalal A; Serya, Rabah ; Abouzid, Khaled AM |
| 2023 | Hit Identification Against Candida Albicans: Design, Synthesis, Molecular Docking and Biological Evaluation of Hybrid Styryl-Quinoxaline Based Analogues. | Jaballah, Maiy Y; Alaraby, Mohamed; Serya, Rabah ; Abouzid, Khaled |
| 15-Dec-2017 | How to train your inhibitor: Design strategies to overcome resistance to Epidermal Growth Factor Receptor inhibitors | Milik, Sandra N ; Lasheen, Deena S; Serya, Rabah ; Abouzid, Khaled A M; Khaled A M Abouzid |
| Dec-2018 | Identification of new pyrrolo[2,3-d]pyrimidines as potent VEGFR-2 tyrosine kinase inhibitors: Design, synthesis, biological evaluation and molecular modeling | Adel, Mai ; Serya, Rabah ; Lasheen, Deena S. ; Khaled A M Abouzid |
| 2023 | Identification of Novel 4-Oxo-4H-chromen-Hydroxamic Acid Derivative Targeting Selected HDAC Isoforms | Ashraf, Rosaline; Serya, Rabah ; Abouzid, Khaled AM; Adel, Mai |
| 2019 | Identification of novel pyrazole and benzimidazole based derivatives as PBP2a inhibitors: Design, synthesis, and biological evaluation | Shalaby, Menna-Allah; Dokla, Eman ; Serya, Rabah ; Abouzid, Khaled |
| Jul-2013 | In silico design: extended molecular dynamic simulations of a new series of dually acting inhibitors against EGFR and HER2 | Ahmed, Marawan; Sadek, Maiada M; Abouzid, Khaled ; Wang, Feng; Serya, Rabah |
| Dec-2024 | Lead generation of Aurora-A kinase inhibitors: Using 3D-QSAR pharmacophore modeling, virtual screening, and molecular docking | Sara A. Hesham; Shahin, Mai I. ; Samar Mowafy; Rabah A. T. Serya ; Nahla A. Farag; Khaled A. M. Abouzid |
| 15-Feb-2006 | Ligand design and synthesis of new imidazo[5,1-b]quinazoline derivatives as alpha1-adrenoceptor agonists and antagonists | Ismail, Mohamed A H; Aboul-Enein, Mohamed N Y; Abouzid, Khaled ; Serya, Rabah A T |
| May-2026 | Ligand-Based Design of Novel Thiazole-Quinazolinone Hybrids with Dual Antimicrobial and Anti-Virulence Activity Targeting Staphylococcal Sortase A | Hammad, Shaymaa G; Aboul-Magd, Dina S; Ghorab, Mostafa M; Adel, Mai ; Serya, Rabah ; El-Hossary, Ebaa M; El-Gazzar, Marwa G; Abouzid, Khaled A M |
| Jun-2014 | Molecular design and synthesis of 1,4-disubstituted piperazines as α(1)-adrenergic receptor blockers | Hussein, Mohammed M; Serya, Rabah ; Abdel Naby, Rana M; Al-Abd, Ahmed M; Saleh, Dalia O; El-Eraky, Wafaa I; Khaled A M Abouzid ; Abou El Ella, Dalal |
| Dec-2022 | Molecular design, synthesis and biological evaluation of novel 1,2,5-trisubstituted benzimidazole derivatives as cytotoxic agents endowed with ABCB1 inhibitory action to overcome multidrug resistance in cancer cells | Abdelhafiz, Abeer H A ; Lasheen, Deena S. ; Wang, Nessa; Sobeh, Mansour; Wink, Michael; Abouzid, Khaled ; Serya, Rabah |
| Dec-2021 | Molecular design, synthesis and in vitro biological evaluation of thienopyrimidine-hydroxamic acids as chimeric kinase HDAC inhibitors: a challenging approach to combat cancer | Abdel-Atty, Mona M; Farag, Nahla A; Serya, Rabah A T ; Abouzid, Khaled ; Mowafy, Samar |
| 2025 | Next-Generation Diarylurea Antibacterials: From Structural Design and Optimization to Microbial Target Specific Strategies | Kassab, Rafif Rashad; Serya, Rabah Ahmed; Serya, Rabah ; Nermin Samir ; Abouzid, Khaled |
| 1-Dec-2017 | Novel quinoline-3-carboxamides (Part 2): Design, optimization and synthesis of quinoline based scaffold as EGFR inhibitors with potent anticancer activity | Aly, Rasha M.; Serya, Rabah ; El-Motwally, Amira M.; Abbas, Safinaz; Abou El Ella, Dalal ; Esmat, Ahmed |
| 15-Mar-2024 | Novel sulfonamide-indolinone hybrids targeting mitochondrial respiration of breast cancer cells | Abdel-Aziz, Amal Kamal ; Ahmed, Tarek E.; Hatem, Yasmin; Abdel Rahman, Engy A.; Sharaky, Marwa; Shahin, Mai I. ; Elrazaz, Eman Z.; Serya, Rabah A.T. ; Henary, Maged; Ali, Sameh S.; Abou El Ella, Dalal A.; Dokla, Eman ; Helmy, Sama |
| 2017 | An overview on the prospective CDKs inhibitors as anti-cancer drugs | Oudah, Khulood H; Serya, R; Abouzid, K; Serya, Rabah ; Nermin Samir |
| 1-Aug-2020 | Penicillin binding protein 2a: An overview and a medicinal chemistry perspective | Shalaby, Menna-Allah W; Dokla, Eman ; Serya, Rabah ; Khaled A M Abouzid |
| 2017 | Pyrazolo [1, 5-a][1, 3, 5] triazine based scaffold as purine analogues with diverse biological activity | Najm, Mazin AA; Serya, Rabah ; Abouzid, Khaled AM |
| 2016 | Pyrazolo[3,4-d]pyrimidine based scaffold derivatives targeting kinases as anticancer agents | Ismail, Nasser S.M.; Ali, Eslam M.H.; Ibrahim, Diaa A.; Serya, Rabah A.T. ; Abou El Ella, Dalal |
| Sep-2018 | Pyrrolopyrimidine, A Multifaceted Scaffold in Cancer Targeted Therapy | Adel, Mai ; Serya, Rabah A T ; Lasheen, Deena S. ; Abouzid, Khaled |
| 2016 | Quinoline-based small molecules as effective protein kinases inhibitors | Aly, Rasha M; Al-Ansary, Ghada H; Abou El Ella, Dalal A; Serya, Rabah ; Amira, M |
| 2016 | Rational design, synthesis and 2D-QSAR studies of antiproliferative tropane-based compounds | Ismail, Nasser SM; George, Riham F; Serya, Rabah ; Baselious, Fady N; El-Manawaty, May; Shalaby, ElSayed M; Girgis, Adel S |
| 2019 | Selective Small Molecule Myeloid Cell Leukemia-1 (MCL-1) Inhibitors: Novel Agents in Cancer Therapy | Ibrahim, Hoda Sobhy; Lasheen, Deena S; Serya, Rabah ; Abu-ELElla, Dalal Abd-ELRahman |
| May-2025 | Structural Optimization and MD Simulation Study of Benzimidazole Derivatives as Potent Mutant FLT3 Kinase Inhibitors Targeting AML | El-Deen, Nada Alaa; DeFilippis, RosaAnna; Milik, Sandra N ; Patel, Suhana; Ismail, Muhammad I; Khaled, Omar; Ahmed, Tarek Erfan; Abdelfattah, Ayatullah Gamal; Ali, Eslam M H; Gaballah, Maiy Y; McPhillie, Martin J; Abouzid, Khaled A M; Henary, Maged; Minucci, Saverio; Shah, Neil P; Abdel-Aziz, Amal Kamal ; Serya, Rabah ; Dokla, Eman |
| Mar-2013 | Structure-based design and synthesis of novel pseudosaccharine derivatives as antiproliferative agents and kinase inhibitors | Elsayed, Mohamed S A; El-Araby, Moustafa E; Serya, Rabah ; El-Khatib, Ahmed H; Linscheid, Michael W; Khaled A M Abouzid |
| 15-Jul-2018 | Surmounting the resistance against EGFR inhibitors through the development of thieno[2,3-d]pyrimidine-based dual EGFR/HER2 inhibitors | Milik, Sandra N ; Serya, Rabah ; Minucci, Saverio; Lasheen, Deena S. ; Khaled A M Abouzid ; Abdel-Aziz, Amal Kamal |
| Feb-2022 | Synthesis and in vitro antiproliferative activity of certain novel pyrazolo[3,4-b]pyridines with potential p38α MAPK-inhibitory activity | Farahat, Aya A; Samir, Eman M; Zaki, Mayssoune Y; Abdel-Aziz, Hatem A; Serya, Rabah |
| 2015 | Synthesis and in vitro antiproliferative activity of novel pyrazolo[3,4-d]pyrimidine derivatives | Abdou, Nermin S.; Serya, Rabah ; Esmat, Ahmed ; Tolba, Mai F.; Ismail, Nasser S. M.; Khaled A M Abouzid ; Nermin Samir |
| 20-Jun-2018 | Synthesis and molecular docking studies of some novel Schiff bases incorporating 6-butylquinolinedione moiety as potential topoisomerase II$\beta$ inhibitors | Hassanin, Hany M; Serya, Rabah ; Abd Elmoneam, Wafaa R; Mostafa, Mai A |
| 6-Jul-2017 | Synthesis, ADMET Properties, and Biological Evaluation of Benzothiazole Compounds Targeting Chemokine Receptor 2 (CXCR2) | Mehanna, Wesam E; Lu, Tiangong; Debnath, Bikash; Lasheen, Deena S. ; Serya, Rabah A T ; Abouzid, Khaled ; Neamati, Nouri |
| 2020 | Synthesis, Biological Evaluation and In Silico Investigation of Novel Functionalized Imidazole-Based KDM6 Inhibitors | Serya, Rabah ; El-Araby, Amr; Qassem, Omar; El-Sawy, Ezzat; El-Razaz, Eman; Abouzid, Khaled |
| 1-Dec-2025 | Tackling microbial resistance with 4H-chromen-4-one derivatives as a novel class of penicillin binding protein 2a inhibitors | Shalaby, Menna-Allah W; Abutaleb, Nader S; Elgammal, Yehia; Liang, Hsin-Wen; Abdallah, Inas A; Fishovitz, Jennifer; Seleem, Mohamed N; Abouzid, Khaled A M; Serya, Rabah ; Dokla, Eman |
| 2015 | Targeting apoptotic machinery as approach for anticancer therapy: Smac mimetics as anticancer agents | Elsayed, NMY; Abou El Ella, D.A. ; Serya, RAT; Abouzid, Khaled ; Serya, Rabah |
| 1-Jul-2025 | Targeting DNA repair mechanisms: Spirobenzoxazinone and salicylamide derivatives as novel candidates for PARP-1 inhibition in cancer therapy | Kadry, Alaa Ahmed ; Adel, Mai ; Abubshait, Samar A; Yahya, Galal; Sharaky, Marwa; Abouzid, Khaled A M; Serya, Rabah |
| 2015 | Thieno[2,3-d]pyrimidine based derivatives as kinase inhibitors and anticancer agents | Elrazaz, Eman ; Abou El Ella, Dalal ; Khaled A M Abouzid ; Rabah A.T. Serya ; Nasser S.M. Ismail |
| Dec-2019 | Towards discovery of novel scaffold with potent antiangiogenic activity; design, synthesis of pyridazine based compounds, impact of hinge interaction, and accessibility of their bioactive conformation on VEGFR-2 activities | Jaballah, Maiy Y; Serya, Rabah ; Saad, Nasser; Khojah, Sohair M; Ahmed, Marawan; Barakat, Khaled; Khaled A M Abouzid |
| Dec-2012 | Virtual screening and synthesis of new chemical scaffolds as VEGFR-2 kinase inhibitors | El-Araby, M E; Serya, Rabah ; Elbarbary, Elsayed M.E.; Khaled A M Abouzid |
